Eric Thaler
Concepts (365)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep Apnea, Obstructive | 29 | 2023 | 230 | 9.660 |
Why?
| Electric Stimulation Therapy | 16 | 2021 | 71 | 5.990 |
Why?
| Implantable Neurostimulators | 7 | 2021 | 12 | 4.100 |
Why?
| Hypoglossal Nerve | 11 | 2022 | 17 | 3.780 |
Why?
| Robotic Surgical Procedures | 6 | 2020 | 86 | 2.780 |
Why?
| Natural Orifice Endoscopic Surgery | 4 | 2020 | 28 | 1.990 |
Why?
| Endoscopy | 14 | 2022 | 265 | 1.660 |
Why?
| Robotics | 4 | 2015 | 89 | 1.470 |
Why?
| Palate, Soft | 4 | 2021 | 13 | 1.380 |
Why?
| Polysomnography | 11 | 2023 | 182 | 1.100 |
Why?
| Otorhinolaryngologic Surgical Procedures | 4 | 2020 | 38 | 1.100 |
Why?
| Tongue | 4 | 2021 | 76 | 1.010 |
Why?
| Electronics, Medical | 5 | 2006 | 12 | 0.990 |
Why?
| Otolaryngology | 2 | 2021 | 82 | 0.910 |
Why?
| Airway Obstruction | 3 | 2022 | 169 | 0.850 |
Why?
| Electrodes | 2 | 2021 | 93 | 0.830 |
Why?
| Sinusitis | 5 | 2018 | 163 | 0.820 |
Why?
| Otorhinolaryngologic Diseases | 1 | 2021 | 16 | 0.820 |
Why?
| Airway Remodeling | 1 | 2021 | 61 | 0.800 |
Why?
| Acromegaly | 1 | 2020 | 15 | 0.760 |
Why?
| Palatine Tonsil | 1 | 2020 | 32 | 0.760 |
Why?
| Treatment Outcome | 23 | 2021 | 9654 | 0.740 |
Why?
| Continuous Positive Airway Pressure | 5 | 2023 | 69 | 0.700 |
Why?
| Internal Medicine | 1 | 2021 | 223 | 0.690 |
Why?
| Sleep Apnea Syndromes | 2 | 2016 | 86 | 0.650 |
Why?
| Middle Aged | 36 | 2021 | 28961 | 0.640 |
Why?
| Tonsillectomy | 3 | 2014 | 76 | 0.640 |
Why?
| Smell | 4 | 2005 | 113 | 0.640 |
Why?
| Pharynx | 2 | 2020 | 54 | 0.630 |
Why?
| Biosensing Techniques | 5 | 2007 | 109 | 0.630 |
Why?
| Prospective Studies | 18 | 2021 | 6629 | 0.620 |
Why?
| Head and Neck Neoplasms | 3 | 2020 | 462 | 0.600 |
Why?
| Humans | 74 | 2023 | 121869 | 0.560 |
Why?
| Male | 49 | 2021 | 60475 | 0.540 |
Why?
| Nose Neoplasms | 5 | 2008 | 21 | 0.520 |
Why?
| Aged | 30 | 2021 | 20705 | 0.510 |
Why?
| Uvula | 1 | 2012 | 4 | 0.460 |
Why?
| Deglutition Disorders | 1 | 2014 | 135 | 0.460 |
Why?
| Mouth | 3 | 2020 | 83 | 0.450 |
Why?
| Cerebrospinal Fluid | 2 | 2005 | 92 | 0.440 |
Why?
| Female | 40 | 2021 | 63903 | 0.440 |
Why?
| Magnetic Resonance Imaging | 8 | 2015 | 3240 | 0.420 |
Why?
| Zenker Diverticulum | 1 | 2010 | 4 | 0.400 |
Why?
| Rhinitis | 4 | 2018 | 116 | 0.390 |
Why?
| Pattern Recognition, Automated | 2 | 2008 | 84 | 0.380 |
Why?
| Electrodes, Implanted | 2 | 2021 | 103 | 0.380 |
Why?
| Sleep, REM | 2 | 2020 | 56 | 0.360 |
Why?
| Biofilms | 2 | 2011 | 244 | 0.360 |
Why?
| Amyloidosis | 2 | 2006 | 41 | 0.350 |
Why?
| Colony Count, Microbial | 2 | 2008 | 121 | 0.350 |
Why?
| Retrospective Studies | 16 | 2020 | 13063 | 0.340 |
Why?
| Glossectomy | 3 | 2020 | 4 | 0.340 |
Why?
| Volatile Organic Compounds | 3 | 2014 | 59 | 0.330 |
Why?
| Learning Curve | 2 | 2020 | 67 | 0.330 |
Why?
| Adult | 23 | 2023 | 32683 | 0.310 |
Why?
| Severity of Illness Index | 5 | 2021 | 2876 | 0.310 |
Why?
| Parotid Diseases | 1 | 2006 | 4 | 0.300 |
Why?
| Submandibular Gland Diseases | 1 | 2006 | 3 | 0.300 |
Why?
| Pseudomonas Infections | 1 | 2008 | 195 | 0.280 |
Why?
| Gram-Negative Bacterial Infections | 1 | 2006 | 41 | 0.280 |
Why?
| Clinical Chemistry Tests | 1 | 2005 | 11 | 0.280 |
Why?
| Diagnostic Techniques and Procedures | 1 | 2005 | 18 | 0.270 |
Why?
| Respiration, Artificial | 4 | 2007 | 568 | 0.270 |
Why?
| Urinalysis | 1 | 2005 | 66 | 0.270 |
Why?
| Biotechnology | 1 | 2005 | 45 | 0.270 |
Why?
| Pseudomonas aeruginosa | 1 | 2008 | 311 | 0.270 |
Why?
| Biomimetics | 1 | 2005 | 41 | 0.270 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2006 | 70 | 0.270 |
Why?
| Blood Chemical Analysis | 1 | 2005 | 97 | 0.260 |
Why?
| Pneumonia | 3 | 2005 | 597 | 0.260 |
Why?
| Serum | 1 | 2005 | 66 | 0.260 |
Why?
| Cerumen | 2 | 2014 | 2 | 0.260 |
Why?
| Evaluation Studies as Topic | 3 | 2021 | 205 | 0.250 |
Why?
| Staphylococcus aureus | 1 | 2008 | 394 | 0.250 |
Why?
| Cohort Studies | 6 | 2021 | 5300 | 0.250 |
Why?
| Specimen Handling | 1 | 2005 | 170 | 0.250 |
Why?
| Staphylococcal Infections | 1 | 2008 | 342 | 0.240 |
Why?
| Paranasal Sinuses | 2 | 2009 | 60 | 0.240 |
Why?
| Sleep Apnea, Central | 1 | 2022 | 10 | 0.230 |
Why?
| Larynx | 2 | 2020 | 55 | 0.230 |
Why?
| Odorants | 3 | 2018 | 127 | 0.230 |
Why?
| Palate | 2 | 2020 | 34 | 0.230 |
Why?
| Predictive Value of Tests | 5 | 2021 | 1965 | 0.210 |
Why?
| Epiglottis | 1 | 2021 | 3 | 0.210 |
Why?
| Skull Base | 2 | 2012 | 42 | 0.210 |
Why?
| Registries | 5 | 2021 | 1956 | 0.210 |
Why?
| Cricoid Cartilage | 2 | 1997 | 15 | 0.200 |
Why?
| Lymphoma, T-Cell | 1 | 2000 | 21 | 0.200 |
Why?
| Macroglossia | 1 | 2020 | 1 | 0.190 |
Why?
| Otolaryngologists | 1 | 2020 | 11 | 0.190 |
Why?
| Video Recording | 2 | 2019 | 159 | 0.190 |
Why?
| Follow-Up Studies | 8 | 2018 | 4883 | 0.190 |
Why?
| Patient Satisfaction | 3 | 2019 | 618 | 0.190 |
Why?
| Laryngeal Neoplasms | 2 | 1998 | 39 | 0.190 |
Why?
| Hypertrophy | 1 | 2020 | 125 | 0.190 |
Why?
| Siderosis | 1 | 1999 | 3 | 0.180 |
Why?
| Hypopharynx | 1 | 2019 | 2 | 0.180 |
Why?
| Hemangioma, Cavernous | 1 | 1999 | 17 | 0.180 |
Why?
| History, 21st Century | 1 | 2020 | 186 | 0.180 |
Why?
| Medical Staff, Hospital | 1 | 2020 | 76 | 0.180 |
Why?
| Paranasal Sinus Neoplasms | 1 | 1999 | 17 | 0.180 |
Why?
| Blood | 1 | 2000 | 104 | 0.180 |
Why?
| History, 20th Century | 1 | 2020 | 298 | 0.180 |
Why?
| Deep Sedation | 1 | 2018 | 11 | 0.170 |
Why?
| Subarachnoid Hemorrhage | 1 | 1999 | 63 | 0.170 |
Why?
| Interprofessional Relations | 1 | 2021 | 267 | 0.170 |
Why?
| Body Mass Index | 2 | 2021 | 2174 | 0.170 |
Why?
| Central Nervous System Diseases | 1 | 1999 | 70 | 0.170 |
Why?
| Aged, 80 and over | 8 | 2018 | 6974 | 0.170 |
Why?
| Product Surveillance, Postmarketing | 1 | 2019 | 70 | 0.170 |
Why?
| Postoperative Complications | 4 | 2020 | 2322 | 0.170 |
Why?
| Respiratory Tract Infections | 1 | 2002 | 322 | 0.170 |
Why?
| Bacterial Infections | 2 | 2011 | 228 | 0.160 |
Why?
| Arytenoid Cartilage | 1 | 1997 | 6 | 0.160 |
Why?
| Anesthesia, Local | 1 | 1997 | 16 | 0.160 |
Why?
| Muscular Atrophy, Spinal | 1 | 1997 | 20 | 0.160 |
Why?
| Killer Cells, Natural | 1 | 2000 | 380 | 0.160 |
Why?
| Skull Base Neoplasms | 2 | 2012 | 28 | 0.160 |
Why?
| Respiratory System | 1 | 2018 | 145 | 0.150 |
Why?
| Patient Compliance | 1 | 2021 | 569 | 0.150 |
Why?
| Conscious Sedation | 1 | 1997 | 80 | 0.150 |
Why?
| Defibrillators, Implantable | 2 | 2018 | 411 | 0.150 |
Why?
| Gas Chromatography-Mass Spectrometry | 3 | 2014 | 144 | 0.150 |
Why?
| Vestibular Nerve | 1 | 1996 | 16 | 0.140 |
Why?
| Wound Healing | 1 | 2018 | 286 | 0.140 |
Why?
| Lymph Nodes | 2 | 2008 | 468 | 0.140 |
Why?
| Prostheses and Implants | 1 | 2017 | 156 | 0.140 |
Why?
| Electronics | 3 | 2007 | 76 | 0.140 |
Why?
| Feasibility Studies | 2 | 2018 | 779 | 0.140 |
Why?
| Meniere Disease | 1 | 1996 | 30 | 0.140 |
Why?
| Imaging, Three-Dimensional | 1 | 2019 | 501 | 0.140 |
Why?
| Biopsy, Fine-Needle | 2 | 2006 | 69 | 0.140 |
Why?
| Carcinoma | 1 | 1997 | 213 | 0.130 |
Why?
| Breath Tests | 2 | 2005 | 88 | 0.130 |
Why?
| Preoperative Period | 1 | 2015 | 114 | 0.130 |
Why?
| Papilloma | 2 | 2008 | 51 | 0.130 |
Why?
| Pneumonia, Viral | 1 | 2020 | 366 | 0.130 |
Why?
| Coronavirus Infections | 1 | 2020 | 356 | 0.130 |
Why?
| Quality of Life | 3 | 2020 | 2453 | 0.130 |
Why?
| Hearing | 1 | 1996 | 132 | 0.120 |
Why?
| Surveys and Questionnaires | 3 | 2021 | 4922 | 0.120 |
Why?
| Clinical Competence | 1 | 2021 | 957 | 0.120 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2014 | 127 | 0.120 |
Why?
| Postoperative Period | 1 | 2015 | 323 | 0.120 |
Why?
| Solid Phase Microextraction | 2 | 2014 | 8 | 0.120 |
Why?
| Pharyngeal Diseases | 1 | 1993 | 16 | 0.120 |
Why?
| Time Factors | 3 | 2019 | 6889 | 0.120 |
Why?
| Branchial Region | 1 | 1993 | 41 | 0.120 |
Why?
| Anesthetics, Intravenous | 3 | 2012 | 34 | 0.120 |
Why?
| Neoplasm Recurrence, Local | 4 | 2008 | 884 | 0.120 |
Why?
| Propofol | 3 | 2012 | 48 | 0.120 |
Why?
| Hypoglossal Nerve Diseases | 1 | 2012 | 3 | 0.120 |
Why?
| Carotid Artery, Internal, Dissection | 1 | 2012 | 8 | 0.110 |
Why?
| Cysts | 1 | 1993 | 91 | 0.110 |
Why?
| Chronic Disease | 5 | 2018 | 1655 | 0.110 |
Why?
| Decision Making | 1 | 2000 | 825 | 0.110 |
Why?
| Diagnosis, Differential | 4 | 2012 | 1425 | 0.110 |
Why?
| Young Adult | 4 | 2015 | 11223 | 0.110 |
Why?
| Diagnostic Errors | 1 | 2012 | 165 | 0.100 |
Why?
| Brain Neoplasms | 1 | 1999 | 1031 | 0.100 |
Why?
| Wounds and Injuries | 1 | 2018 | 822 | 0.100 |
Why?
| Anesthetics, Combined | 2 | 2000 | 7 | 0.090 |
Why?
| Internship and Residency | 1 | 2020 | 1045 | 0.090 |
Why?
| Papilloma, Inverted | 2 | 1999 | 3 | 0.090 |
Why?
| Bacteria | 2 | 2009 | 764 | 0.090 |
Why?
| Budesonide | 1 | 2010 | 88 | 0.090 |
Why?
| Thyroglobulin | 1 | 2008 | 18 | 0.090 |
Why?
| Mucus | 1 | 2009 | 57 | 0.090 |
Why?
| Midazolam | 2 | 2000 | 50 | 0.090 |
Why?
| Algorithms | 2 | 2008 | 1618 | 0.090 |
Why?
| Human papillomavirus 6 | 1 | 2008 | 4 | 0.090 |
Why?
| Germany | 2 | 2019 | 89 | 0.080 |
Why?
| Carcinoma, Squamous Cell | 3 | 1999 | 625 | 0.080 |
Why?
| Carcinoma, Papillary | 1 | 2008 | 76 | 0.080 |
Why?
| Piperidines | 2 | 2000 | 167 | 0.080 |
Why?
| Case-Control Studies | 3 | 2020 | 3314 | 0.080 |
Why?
| Oxygen | 1 | 2012 | 878 | 0.080 |
Why?
| Obesity | 1 | 2021 | 2802 | 0.080 |
Why?
| Hydrazones | 1 | 2007 | 25 | 0.080 |
Why?
| Operative Time | 2 | 2020 | 116 | 0.080 |
Why?
| Pyridazines | 1 | 2007 | 59 | 0.080 |
Why?
| Myocardial Revascularization | 1 | 2007 | 87 | 0.080 |
Why?
| Hydrocortisone | 1 | 2010 | 333 | 0.080 |
Why?
| Congo Red | 1 | 2006 | 9 | 0.080 |
Why?
| Anti-Arrhythmia Agents | 1 | 2007 | 139 | 0.070 |
Why?
| Coloring Agents | 1 | 2006 | 73 | 0.070 |
Why?
| Amyloid | 1 | 2006 | 86 | 0.070 |
Why?
| Myocardial Ischemia | 1 | 2007 | 270 | 0.070 |
Why?
| Transducers | 1 | 2005 | 28 | 0.070 |
Why?
| Tumor Cells, Cultured | 1 | 2007 | 907 | 0.070 |
Why?
| Thyroid Neoplasms | 1 | 2008 | 269 | 0.070 |
Why?
| Postoperative Care | 2 | 2016 | 241 | 0.070 |
Why?
| Nasal Polyps | 2 | 2010 | 44 | 0.070 |
Why?
| Papillomavirus Infections | 1 | 2008 | 273 | 0.070 |
Why?
| Salivary Gland Diseases | 1 | 2004 | 3 | 0.060 |
Why?
| Positive-Pressure Respiration | 1 | 2005 | 69 | 0.060 |
Why?
| Neoplasm Invasiveness | 4 | 2000 | 466 | 0.060 |
Why?
| Reproducibility of Results | 2 | 2012 | 2999 | 0.060 |
Why?
| Neck | 2 | 2008 | 90 | 0.060 |
Why?
| Coronary Artery Bypass | 2 | 2007 | 263 | 0.060 |
Why?
| Tomography, X-Ray Computed | 4 | 2018 | 2519 | 0.060 |
Why?
| Intubation, Intratracheal | 1 | 2005 | 211 | 0.060 |
Why?
| Syndrome | 1 | 2022 | 365 | 0.050 |
Why?
| Body Fluids | 1 | 2001 | 63 | 0.050 |
Why?
| Acoustics | 1 | 2001 | 56 | 0.050 |
Why?
| Sufentanil | 1 | 2000 | 1 | 0.050 |
Why?
| Survival Rate | 3 | 2007 | 1828 | 0.050 |
Why?
| Orbital Neoplasms | 1 | 2000 | 22 | 0.050 |
Why?
| Airway Management | 1 | 2020 | 50 | 0.050 |
Why?
| In Situ Hybridization | 1 | 2000 | 327 | 0.050 |
Why?
| Semiconductors | 1 | 2000 | 36 | 0.050 |
Why?
| International Cooperation | 1 | 2020 | 178 | 0.050 |
Why?
| Image Enhancement | 3 | 2012 | 180 | 0.050 |
Why?
| Ethmoid Sinus | 1 | 1999 | 8 | 0.050 |
Why?
| Neoplasm Staging | 3 | 1999 | 1237 | 0.050 |
Why?
| Sphenoid Sinus | 1 | 1999 | 9 | 0.050 |
Why?
| Comparative Effectiveness Research | 1 | 2020 | 141 | 0.050 |
Why?
| Retreatment | 1 | 2019 | 72 | 0.040 |
Why?
| Anesthesia, Intravenous | 1 | 1999 | 12 | 0.040 |
Why?
| Preoperative Care | 2 | 2018 | 344 | 0.040 |
Why?
| Nasal Cavity | 1 | 1999 | 52 | 0.040 |
Why?
| Oropharynx | 1 | 2019 | 39 | 0.040 |
Why?
| Risk Factors | 5 | 2023 | 9419 | 0.040 |
Why?
| Critical Pathways | 1 | 1999 | 75 | 0.040 |
Why?
| Neoplasms, Multiple Primary | 1 | 1999 | 58 | 0.040 |
Why?
| Hearing Loss, Sensorineural | 1 | 1999 | 58 | 0.040 |
Why?
| Craniotomy | 1 | 1999 | 71 | 0.040 |
Why?
| Pharyngeal Neoplasms | 1 | 1998 | 4 | 0.040 |
Why?
| Patient Reported Outcome Measures | 1 | 2020 | 244 | 0.040 |
Why?
| Meningioma | 1 | 1999 | 82 | 0.040 |
Why?
| Virtual Reality | 1 | 2019 | 47 | 0.040 |
Why?
| Adjuvants, Anesthesia | 1 | 1997 | 8 | 0.040 |
Why?
| United States | 3 | 2020 | 13209 | 0.040 |
Why?
| Laryngeal Diseases | 1 | 1997 | 21 | 0.040 |
Why?
| Hemostasis, Surgical | 1 | 1997 | 24 | 0.040 |
Why?
| Lidocaine | 1 | 1997 | 40 | 0.040 |
Why?
| Antiemetics | 1 | 1997 | 36 | 0.040 |
Why?
| Asthma | 1 | 2011 | 2130 | 0.040 |
Why?
| Tongue Neoplasms | 1 | 1997 | 21 | 0.040 |
Why?
| Anesthesia, General | 1 | 1997 | 51 | 0.040 |
Why?
| Thyroid Cartilage | 1 | 1997 | 4 | 0.040 |
Why?
| Elastic Tissue | 1 | 1997 | 8 | 0.040 |
Why?
| Laryngeal Mucosa | 1 | 1997 | 8 | 0.040 |
Why?
| Nausea | 1 | 1997 | 109 | 0.040 |
Why?
| Fentanyl | 1 | 1997 | 64 | 0.040 |
Why?
| Laryngectomy | 1 | 1997 | 20 | 0.040 |
Why?
| Blood Loss, Surgical | 1 | 1997 | 90 | 0.040 |
Why?
| Anesthetics, Local | 1 | 1997 | 84 | 0.040 |
Why?
| Vomiting | 1 | 1997 | 131 | 0.040 |
Why?
| Ligaments | 1 | 1997 | 44 | 0.040 |
Why?
| Wound Closure Techniques | 1 | 2016 | 10 | 0.040 |
Why?
| Betacoronavirus | 1 | 2020 | 270 | 0.040 |
Why?
| Hypnotics and Sedatives | 1 | 1997 | 145 | 0.040 |
Why?
| Intraoperative Complications | 1 | 1997 | 136 | 0.040 |
Why?
| Endolymphatic Sac | 1 | 1996 | 1 | 0.040 |
Why?
| Length of Stay | 2 | 2014 | 1056 | 0.040 |
Why?
| Cochlear Nerve | 1 | 1996 | 8 | 0.040 |
Why?
| Audiometry, Pure-Tone | 1 | 1996 | 25 | 0.040 |
Why?
| Arrhythmias, Cardiac | 1 | 1999 | 324 | 0.040 |
Why?
| Sleep | 1 | 2022 | 794 | 0.040 |
Why?
| Ear, Inner | 1 | 1996 | 34 | 0.030 |
Why?
| Pain, Postoperative | 1 | 1997 | 212 | 0.030 |
Why?
| Safety | 1 | 1997 | 313 | 0.030 |
Why?
| Cross-Sectional Studies | 2 | 2020 | 4713 | 0.030 |
Why?
| Cocaine | 1 | 1997 | 159 | 0.030 |
Why?
| Pain Measurement | 1 | 1997 | 484 | 0.030 |
Why?
| Cause of Death | 1 | 1997 | 400 | 0.030 |
Why?
| Ventricular Dysfunction, Left | 1 | 1999 | 398 | 0.030 |
Why?
| Ear | 1 | 2014 | 30 | 0.030 |
Why?
| Burnout, Professional | 1 | 2020 | 323 | 0.030 |
Why?
| Deafness | 1 | 1996 | 80 | 0.030 |
Why?
| Nasal Obstruction | 2 | 2008 | 27 | 0.030 |
Why?
| Speech Perception | 1 | 1996 | 89 | 0.030 |
Why?
| Ion Channels | 1 | 2014 | 128 | 0.030 |
Why?
| Sex Factors | 1 | 2020 | 1898 | 0.030 |
Why?
| Contrast Media | 2 | 2012 | 373 | 0.030 |
Why?
| Monitoring, Intraoperative | 2 | 2007 | 47 | 0.030 |
Why?
| Calcium Channels | 1 | 2014 | 159 | 0.030 |
Why?
| Surgical Wound Infection | 1 | 2016 | 253 | 0.030 |
Why?
| Guidelines as Topic | 1 | 1996 | 272 | 0.030 |
Why?
| Anxiety | 1 | 2020 | 873 | 0.030 |
Why?
| Sensitivity and Specificity | 3 | 2007 | 1871 | 0.030 |
Why?
| Logistic Models | 1 | 2019 | 2037 | 0.030 |
Why?
| Echo-Planar Imaging | 1 | 2012 | 21 | 0.030 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2018 | 1254 | 0.030 |
Why?
| Benchmarking | 1 | 2014 | 180 | 0.030 |
Why?
| Adenocarcinoma | 1 | 1999 | 833 | 0.030 |
Why?
| Gadolinium | 1 | 2012 | 82 | 0.030 |
Why?
| RNA, Ribosomal, 16S | 1 | 2014 | 526 | 0.030 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2012 | 91 | 0.030 |
Why?
| Pandemics | 1 | 2020 | 1316 | 0.030 |
Why?
| Pain | 1 | 1997 | 745 | 0.030 |
Why?
| Observer Variation | 1 | 2012 | 316 | 0.030 |
Why?
| Stress, Psychological | 1 | 2020 | 1067 | 0.030 |
Why?
| Depression | 1 | 2020 | 1201 | 0.030 |
Why?
| Combined Modality Therapy | 2 | 2008 | 1202 | 0.020 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2012 | 225 | 0.020 |
Why?
| Incidence | 1 | 1997 | 2520 | 0.020 |
Why?
| Administration, Intranasal | 1 | 2010 | 76 | 0.020 |
Why?
| Therapeutic Irrigation | 1 | 2010 | 72 | 0.020 |
Why?
| Thyroidectomy | 1 | 2008 | 53 | 0.020 |
Why?
| Reoperation | 1 | 2011 | 578 | 0.020 |
Why?
| Nasal Septum | 1 | 2008 | 17 | 0.020 |
Why?
| Iodine Radioisotopes | 1 | 2008 | 129 | 0.020 |
Why?
| Pituitary-Adrenal System | 1 | 2010 | 184 | 0.020 |
Why?
| Debridement | 1 | 2008 | 94 | 0.020 |
Why?
| Image Processing, Computer-Assisted | 1 | 2012 | 727 | 0.020 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2010 | 220 | 0.020 |
Why?
| Intra-Aortic Balloon Pumping | 1 | 2007 | 24 | 0.020 |
Why?
| Lymphatic Metastasis | 1 | 2008 | 312 | 0.020 |
Why?
| Volatilization | 1 | 2007 | 64 | 0.020 |
Why?
| Microbiota | 1 | 2014 | 631 | 0.020 |
Why?
| Catecholamines | 1 | 2007 | 116 | 0.020 |
Why?
| Shock, Cardiogenic | 1 | 2007 | 64 | 0.020 |
Why?
| Principal Component Analysis | 1 | 2007 | 187 | 0.020 |
Why?
| Recurrence | 1 | 2010 | 1002 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2014 | 2107 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2007 | 387 | 0.020 |
Why?
| Emergencies | 1 | 2007 | 161 | 0.020 |
Why?
| Adolescent | 2 | 2014 | 19126 | 0.020 |
Why?
| Vascular Resistance | 1 | 2007 | 389 | 0.020 |
Why?
| DNA, Viral | 1 | 2008 | 388 | 0.020 |
Why?
| Discriminant Analysis | 1 | 2005 | 42 | 0.020 |
Why?
| In Vitro Techniques | 1 | 2007 | 1137 | 0.020 |
Why?
| Adipose Tissue | 2 | 2000 | 632 | 0.020 |
Why?
| Hemodynamics | 2 | 2000 | 1047 | 0.020 |
Why?
| Thorax | 1 | 2004 | 48 | 0.020 |
Why?
| Acute Disease | 1 | 2007 | 986 | 0.020 |
Why?
| Biopsy | 1 | 2008 | 1090 | 0.020 |
Why?
| Endocarditis | 1 | 2004 | 41 | 0.020 |
Why?
| Heart Rate | 1 | 2007 | 788 | 0.010 |
Why?
| Heart Valve Diseases | 1 | 2004 | 140 | 0.010 |
Why?
| Intensive Care Units | 1 | 2005 | 618 | 0.010 |
Why?
| Lacrimal Apparatus Diseases | 1 | 2000 | 5 | 0.010 |
Why?
| Intraoperative Care | 1 | 2000 | 48 | 0.010 |
Why?
| Oculomotor Muscles | 1 | 2000 | 41 | 0.010 |
Why?
| Blood Pressure | 1 | 2007 | 1717 | 0.010 |
Why?
| Radiographic Image Enhancement | 1 | 2000 | 67 | 0.010 |
Why?
| Infant | 1 | 1993 | 8440 | 0.010 |
Why?
| Critical Care | 1 | 2004 | 528 | 0.010 |
Why?
| Pennsylvania | 1 | 1999 | 96 | 0.010 |
Why?
| Child, Preschool | 1 | 1993 | 9776 | 0.010 |
Why?
| Dobutamine | 1 | 1999 | 37 | 0.010 |
Why?
| Diagnostic Techniques, Surgical | 1 | 1998 | 1 | 0.010 |
Why?
| Neck Muscles | 1 | 1998 | 12 | 0.010 |
Why?
| Fascia | 1 | 1998 | 17 | 0.010 |
Why?
| Fasciotomy | 1 | 1998 | 18 | 0.010 |
Why?
| Health Resources | 1 | 1999 | 137 | 0.010 |
Why?
| Gadolinium DTPA | 1 | 1998 | 54 | 0.010 |
Why?
| Cardiotonic Agents | 1 | 1999 | 134 | 0.010 |
Why?
| Forecasting | 1 | 2000 | 382 | 0.010 |
Why?
| Neck Dissection | 1 | 1997 | 10 | 0.010 |
Why?
| Actuarial Analysis | 1 | 1997 | 33 | 0.010 |
Why?
| Surgical Wound Dehiscence | 1 | 1997 | 21 | 0.010 |
Why?
| Melanoma | 1 | 2004 | 705 | 0.010 |
Why?
| Radiotherapy Dosage | 1 | 1997 | 245 | 0.010 |
Why?
| Cervical Vertebrae | 1 | 1998 | 115 | 0.010 |
Why?
| Gastrostomy | 1 | 1997 | 90 | 0.010 |
Why?
| Treatment Failure | 1 | 1997 | 343 | 0.010 |
Why?
| Radiotherapy | 1 | 1997 | 192 | 0.010 |
Why?
| Skin Neoplasms | 1 | 2004 | 837 | 0.010 |
Why?
| Tracheostomy | 1 | 1997 | 94 | 0.010 |
Why?
| Enteral Nutrition | 1 | 1997 | 172 | 0.010 |
Why?
| Disease-Free Survival | 1 | 1997 | 678 | 0.010 |
Why?
| Prognosis | 1 | 1997 | 3603 | 0.010 |
Why?
|
|
Thaler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|